Skip to content
Menu

Celularity Inc. GXGX

Full chart Compare
Set alert

Price alert · GXGX

All alert types
10.20 +10.20

Day range unavailable

52-week range unavailable

Included in Essentials and up

Sign in to see Fair value

Discounted cash flow estimates against the price, and the P/E against its industry and sector.

Included in Essentials and up

Sign in to see Head count and owner earnings

Employees by annual report and the cash the business earns for its owners.

Financial health

Altman Z-Score

-8.29 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -2.8×
FY 2019: 32.1×FY 2020: -39.3×FY 2023: -0.9×FY 2024: -3.9×FY 2025: -2.8×
FY 2019 5y median -2.8× FY 2025
P/S 9.8×
FY 2019: 0.0×FY 2020: 0.0×FY 2023: 84.4×FY 2024: 4.1×FY 2025: 9.8×
FY 2019 5y median 4.1× FY 2025
P/B -6.9×
FY 2019: 0.3×FY 2020: 17633×FY 2023: 0.0×FY 2024: 25.3×FY 2025: -6.9×
FY 2019 5y median 0.3× FY 2025
P/FCF -19.7×
FY 2019: -72.6×FY 2020: -74.7×FY 2023: 0.0×FY 2024: -34.0×FY 2025: -19.7×
FY 2019 5y median -34.0× FY 2025
EV/EBITDA 44.3×
FY 2019: 24.8×FY 2020: -36.1×FY 2023: 0.0×FY 2024: 31.8×FY 2025: 44.3×
FY 2019 5y median 24.8× FY 2025
EV/Sales 12.2×
FY 2019: 0.0×FY 2020: 0.0×FY 2023: 0.0×FY 2024: 4.6×FY 2025: 12.2×
FY 2019 5y median 0.0× FY 2025
FCF Yield -5.1%
FY 2019: -1.4%FY 2020: -1.3%FY 2023: 0.0%FY 2024: -2.9%FY 2025: -5.1%
FY 2019 5y median -1.4% FY 2025

Profitability

Gross Margin 76.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2023: 0.0%FY 2024: 83.6%FY 2025: 76.0%
FY 2019 5y median 0.0% FY 2025
Operating Margin -230.9%
FY 2019: 0.0%FY 2020: 0.0%FY 2023: -844.4%FY 2024: -70.7%FY 2025: -230.9%
FY 2019 5y median -70.7% FY 2025
Net Margin -345.8%
FY 2019: 0.0%FY 2020: 0.0%FY 2023: -862.0%FY 2024: -106.8%FY 2025: -345.8%
FY 2019 5y median -106.8% FY 2025
ROE 241.2%
FY 2019: 0.9%FY 2020: -44940.0%FY 2023: 0.0%FY 2024: -655.1%FY 2025: 241.2%
FY 2019 5y median 0.0% FY 2025
ROIC -169.7%
FY 2019: -0.2%FY 2020: -1346.4%FY 2023: 0.0%FY 2024: -47.1%FY 2025: -169.7%
FY 2019 5y median -47.1% FY 2025
ROA -85.5%
FY 2019: 0.9%FY 2020: -769.1%FY 2023: 0.0%FY 2024: -43.6%FY 2025: -85.5%
FY 2019 5y median -43.6% FY 2025

Growth (YoY)

Revenue -51.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2023: 0.0%FY 2024: 138.1%FY 2025: -51.0%
FY 2019 FY 2025
Operating Income -59.8%
FY 2019: 0.0%FY 2020: -648.2%FY 2023: 0.0%FY 2024: 80.1%FY 2025: -59.8%
FY 2019 FY 2025
EPS (diluted) -36.0%
FY 2019: 0.0%FY 2020: -190.3%FY 2023: 0.0%FY 2024: 76.0%FY 2025: -36.0%
FY 2019 FY 2025
Free Cash Flow -102.0%
FY 2019: 0.0%FY 2020: -7.6%FY 2023: 0.0%FY 2024: 0.0%FY 2025: -102.0%
FY 2019 FY 2025

Financial Health

Current Ratio 0.2×
FY 2019: 4.4×FY 2020: 0.1×FY 2023: 0.0×FY 2024: 0.4×FY 2025: 0.2×
FY 2019 5y median 0.2× FY 2025
Quick Ratio 0.1×
FY 2019: 4.4×FY 2020: 0.1×FY 2023: 0.0×FY 2024: 0.3×FY 2025: 0.1×
FY 2019 5y median 0.1× FY 2025
Debt / Equity -1.8×
FY 2019: 0.0×FY 2020: 0.0×FY 2023: 0.0×FY 2024: 3.3×FY 2025: -1.8×
FY 2019 5y median 0.0× FY 2025
Net Debt / EBITDA 8.5×
FY 2019: -0.3×FY 2020: 0.0×FY 2023: 0.0×FY 2024: 3.6×FY 2025: 8.5×
FY 2019 5y median 0.0× FY 2025
Interest Coverage 9.1×
FY 2019: 0.0×FY 2020: 0.0×FY 2023: 63.8×FY 2024: 6.1×FY 2025: 9.1×
FY 2019 5y median 6.1× FY 2025

Dividends

Dividend Yield 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2019 5y median 0.0% FY 2025
Payout Ratio -0.1%
FY 2019: 0.0%FY 2020: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: -0.1%
FY 2019 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31